2023 Insights event brings pharma and Prime/MRx leaders together

More than 300 pharma representatives attended this annual gathering to learn more about what Prime/MRx has to offer

November 2, 2023

The Insights event took place in Orange County, CA where Prime/MRx trade team members and executives shared company updates and networked with key industry representatives and pharmaceutical manufacturers.

On the agenda

Topic-focused presentations:

  • A government affairs update
  • The latest information on oncology programs, including IntegratedRx®
  • Health outcomes case studies on value-based contracting, GLP-1 and HighTouchRx®
  • A specialty drug management session

Informative panels: Two panels gave the pharma audience a chance to ask the Prime/MRx team questions on their minds.

  • The first as a fireside chat featuring pharmacy benefit management leadership addressing topics including the Prime/MRx integration, corporate strategy and future vision.
  • The second panel included a rotating cast of trade team members representing all lines of business addressing how Prime/MRx and pharma can best work together to maximize patient outcomes.

Networking: The event opened with an evening reception before the formal program began. The reception included a “speed networking” session to close out Day 1 aimed at mixing up attendees and staff in a casual, get-to-know-you format.

“I have received incredible feedback from our attendees on the success of this year’s Insights event. Everyone enjoyed the location, the content and the networking. We look forward to continuing to advance our relationship with pharma through this event and other connections throughout the year,” said Emily Colaizy, assistant vice president, pharmaceutical trade relations.

Related news


May 15, 2024

Prime/MRx experts share clinical insights for migraine treatment

Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs


May 14, 2024

Prime/MRx real-world GLP-1 persistence and adherence data published in Journal of Managed Care & Specialty Pharmacy

Among the key findings from the study — among 4,066 members, Prime/MRx found 1 in 3 stayed on their GLP-1 and 27% took their medication as intended


May 14, 2024

Prime/MRx releases its first corporate social responsibility report

New report, an evolution of previous DEI reports, aims to demonstrate transparency and accountability for company’s corporate social responsibility journey